How to use scorecard? Learn more
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
29.40 | 7.92 | 1.26% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
32.55 | 4.44 | 0.89% |
Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•Bloomberg Quint
1 month ago•The Hindu Businessline
1 month ago•Business Standard
1 month ago•Moneycontrol
1 month ago•Bloomberg Quint
1 month ago•Business Standard
1 month ago•Economic Times
1 month ago•The Hindu Businessline
Interim • Div/Share: ₹ 1
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant